A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 9/50 (2006.01) A61K 31/40 (2006.01) A61K 31/4706 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2601762
A dosage form that includes a cholesteryl ester transfer protein inhibitor in a solubility-improved form and an HMG-CoA reductase inhibitor, wherein the dosage form provides immediate release of the HMG-CoA reductase inhibitor and controlled release and immediate release of the cholesteryl ester transfer protein inhibitor.
La présente invention a trait à une forme de dosage comportant un inhibiteur de protéines de transfert d'ester de cholestéryle sous une forme à solubilité améliorée et un inhibiteur de HMG-CoA réductase, ladite forme de dosage assurant la libération instantanée de l'inhibiteur de HMG-CoA réductase et la libération contrôlée et la libération instantanée de l'inhibiteur des protéines de transfert d'ester de cholestéryle
Berchielli Alfred
Eisenhart Eric Karl
Herbig Scott Max
Johnson Barbara Alice
Pfizer Products Inc.
Sim & Mcburney
LandOfFree
Dosage forms providing controlled and immediate release of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dosage forms providing controlled and immediate release of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage forms providing controlled and immediate release of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1814326